These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 16785468

  • 1. Patient characteristics not described.
    Lofsky S.
    CMAJ; 2006 Jun 20; 174(13):1874. PubMed ID: 16785468
    [No Abstract] [Full Text] [Related]

  • 2. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E, Schnell O.
    Diabetes Care; 2008 Feb 20; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract] [Full Text] [Related]

  • 3. Insulin initiation in Type 2 diabetes.
    Page S.
    Diabet Med; 2005 Sep 20; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract] [Full Text] [Related]

  • 4. Glyburide/metformin (Glucovance) for type 2 diabetes.
    Med Lett Drugs Ther; 2000 Nov 13; 42(1092):105-6. PubMed ID: 11077467
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
    Rupprecht E, König E, Limmer J.
    Pol Tyg Lek; 1993 Apr 13; 48 Suppl 1():31-2. PubMed ID: 8516203
    [No Abstract] [Full Text] [Related]

  • 6. Follow-up of intensive glucose control in type 2 diabetes.
    Petrie JR.
    N Engl J Med; 2009 Jan 22; 360(4):416-7; author reply 418. PubMed ID: 19172672
    [No Abstract] [Full Text] [Related]

  • 7. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I.
    N Engl J Med; 2009 Jan 22; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Choosing first-line therapy for management of type 2 diabetes.
    Graber MA, Darby-Stewart A, Dachs R.
    Am Fam Physician; 2008 Jan 01; 77(1):16-7. PubMed ID: 18236820
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D.
    Diabetes Obes Metab; 2008 Jun 01; 10 Suppl 1():16-24. PubMed ID: 18435670
    [Abstract] [Full Text] [Related]

  • 12. Do we need new drugs for the treatment of type 2 diabetes mellitus?
    Vervoort G, Tack CJ.
    Neth J Med; 2007 May 01; 65(5):157-9. PubMed ID: 17519510
    [No Abstract] [Full Text] [Related]

  • 13. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
    Medina Santillán R, Reyes-García G, Mateos-García E.
    Proc West Pharmacol Soc; 2002 May 01; 45():137-8. PubMed ID: 12434558
    [No Abstract] [Full Text] [Related]

  • 14. The new oral antidiabetic drugs.
    Moss JM, Delawter DE.
    Am Fam Physician; 1984 Nov 01; 30(5):119-21. PubMed ID: 6437197
    [No Abstract] [Full Text] [Related]

  • 15. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
    Comaschi M, Corsi A, Di Pietro C, Bellatreccia A, Mariz S, COM06 Study Investigators.
    Nutr Metab Cardiovasc Dis; 2008 Jun 01; 18(5):373-9. PubMed ID: 17919894
    [Abstract] [Full Text] [Related]

  • 16. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?].
    Mehnert H.
    Dtsch Med Wochenschr; 1989 Jul 07; 114(27):1086-8. PubMed ID: 2500320
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ.
    Diabetes Obes Metab; 2008 Mar 07; 10(3):238-45. PubMed ID: 18269639
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.